CellaVision

At CellaVision, we believe visions can change things – for yourself and for others. CellaVision offers solutions that enable laboratories at hospitals of all sizes to efficiently operate in an advanced workflow, from smearing slides to using high-quality stains, before samples are analyzed and pre-classified through our instruments for digital cell morphology. By streamlining the workflow, accurate results can be generated at a faster pace. Here is what our customers say: “Without CellaVision, we wouldn’t have been able to accelerate turnaround times or improve standardization.” Dr Kristy Carnevale of Cincinnati Children’s Hospital Medical Center “We’re putting a lot of effort into education to ‘future-proof’ our operations. This would be impossible without CellaVision.” Camilla Streimer, Biomedical scientist and Laboratory Process Manager hematology at Region Skåne Learn more about our solutions and our products on our website: https://lnkd.in/drPieV5R

💡 Did you know that with the CellaVision Confirm Cell Counter Results option, users have a straightforward method to streamline the validation of cell counts? This feature in the User Interface significantly enhances the workflow by allowing technicians to quickly screen images and compare results to the automated differential provided by cell counters. Discover how this feature can improve your laboratory processes: https://lnkd.in/dvrnUZJF

🌟 From Humble Beginnings to Global Leadership: Celebrating 30 Years of CellaVision 🌟    This year marks a significant milestone for CellaVision as we celebrate 30 years of pioneering advancements in digital microscopy. As part of our anniversary celebration, we’re launching a short series of posts that will explore our remarkable journey over the past three decades.     In 1994, Christer Fåhraeus laid the foundation for CellaVision with a visionary goal: to revolutionize automated microscopic analysis. The journey began with an ambitious concept — a multifunctional machine designed to create stain and image slides using a patented circular microscope. A pivotal change occurred in 1998 when Yvonne Mårtensson joined as CEO. Under her leadership, the focus was put on imaging and AI, driving the business to new heights.     Fast forward to today, we have transformed from a small team into a global leader, with over 230 dedicated employees and more than 8,000 units sold across 40+ countries. As we reflect on our journey, we look forward to sharing the history of our devices and software, along with the groundbreaking innovations and valuable partnerships that have shaped our success.    Here’s to the next chapter! 🚀 

🌍 Join the CellaVision Global Test 2024:4! 🌍 We’re excited to announce the fourth CellaVision Global Test of the year — a blood cell morphology challenge open to laboratory personnel, physicians, students, and anyone passionate about morphology! What to Expect: We invite participants to classify cells and compare results using our web-based CellaVision Proficiency Software. It's a fantastic opportunity to see how your classification skills stack up against others globally and to explore differences in reporting between countries. This year, we've introduced three difficulty levels, and Global Test 2024:4 is categorized as Level 2—perfect for those looking for a challenge without being overwhelming! Simply sign up on our website before November 13 to participate - https://lnkd.in/dtB4qPcn.

This morning, CellaVision published its interim report for the third quarter of 2024! You can read the full report here: https://lnkd.in/eizMneQ9.

Let’s dive deep into the fascinating world of neutrophil classification and morphology! A few weeks ago CellaVision invited you to participate in our third Global Test of the year — a blood cell morphology challenge! This is a fantastic opportunity for morphology enthusiasts to classify cells and compare results with others using our web-based CellaVision Proficiency Software. The results are out! Check them out here – https://lnkd.in/gD_YpN8i.

🎉 Celebrating 30 Years of Innovation at CellaVision! 🎉 We are thrilled to mark this incredible milestone as CellaVision turns 30! Over the past three decades, we've revolutionized digital cell morphology and transformed laboratory diagnostics worldwide. To commemorate this special occasion, we've created a heartwarming video featuring many of our dedicated employees from around the globe, all coming together to say "Happy Birthday!" Their passion and commitment have been the driving force behind our success. Thank you to our amazing team, partners, and customers for your continued support and collaboration. Here’s to many more years of innovation and excellence!

We’re excited to share the recording of our recent webinar on Digital Cell Morphology Case studies, featuring the esteemed Steven Marionneaux, PhD, MLS(ASCP) from CellaVision and Rutgers University. In this insightful session, Steven delved into several remarkable case studies that showcased how our technology is revolutionizing efficiency, accuracy, and connectivity in clinical laboratories. A special thank you to Sysmex America, Inc. for hosting this event! Don’t miss this opportunity to learn from an expert in the field and explore the future of clinical diagnostics! You can watch the webinar in it’s entirety here - https://lnkd.in/dTFZ-5HE.

Crafted to smear safely, stain consistently, and analyze confidently.     With the DIFF-Line™ by CellaVision you can streamline the entire peripheral blood smear process and enhance efficiency for low-volume labs.    ✅ RAL SmearBox enhaces quality and safety.  ✅ RAL StainBox ensures consistency and traceability.  ✅ The CellaVision DC-1 provides proficiency and connectivity.     🔗 Learn more about the CellaVision Diff-Line and how it can benefit your lab - https://lnkd.in/dRhqFM-x.

Are you ready for a new Cell Challenge? Swipe through the carousel and see if you can diagnose the case. Comment your guess below and visit our website for the answer. This month's case features a 47-year-old male presenting with cough, fever, unexpected weight loss, pain, and generalized lymphadenopathy. Find the answer here - https://lnkd.in/d9GyNF7j.